The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy

por Yan, Youchen, Tang, Rong, Li, Bin, Cheng, Liangping, Ye, Shangmei, Yang, Tiqun, Han, Yan-Chuang, Liu, Chen, Dong, Yugang, Qu, Liang-Hu, Lui, Kathy O., Yang, Jian-Hua, Huang, Zhan-Peng
Publicado 2021

Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2

por Sun, Yu, Chen, Cong, Xue, Ruicong, Wang, Yan, Dong, Bin, Li, Jiayong, Chen, Chen, Jiang, Jingzhou, Fan, Wendong, Liang, Zhuomin, Huang, Huiling, Fang, Rong, Dai, Gang, Yan, Youchen, Yang, Tiqun, Li, Xiangxue, Huang, Zhan-Peng, Dong, Yugang, Liu, Chen
Publicado 2019

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure

por Yan, Youchen, Long, Tianxin, Su, Qiao, Wang, Yi, Chen, Ken, Yang, Tiqun, Zhao, Guangyin, Ma, Qing, Hu, Xiaoyun, Liu, Chen, Liao, Xinxue, Min, Wang, Li, Shujuan, Zhang, Dihua, Yang, Yuedong, Pu, William T., Dong, Yugang, Wang, Da-Zhi, Chen, Yili, Huang, Zhan-Peng
Publicado 2022